Integrated Filing — IndAS

General information about company
Scrip Code	533179
NSE Symbol	PERSISTENT
MSEI Symbol	NOTLISTED
ISIN	INE262H01021
Name of company	Persistent Systems Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	24-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	23-Apr-2025   22:45:00
End date and time of board meeting	24-Apr-2025   04:45:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	32421120000	119387170000
	Other income	183610000	1381540000
	Total income	32604730000	120768710000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	22797270000	86228820000
(e)	Finance costs	184620000	671290000
(f)	Depreciation, depletion and amortisation expense	791020000	3069100000
(f)	Other Expenses
1	Purchase of software licenses	2177980000	7479330000
2	Legal and professional fees	442710000	1647810000
3	Travelling and conveyance	490290000	1710770000
4	Miscellaneous expenses	160970000	691180000
5	Recruitment expenses	65310000	210860000
6	Advertisement, conference and sponsorship fees	27740000	194610000
7	Rent	41860000	143410000
8	Allowance for expected credit loss (net)	168050000	422180000
9	Training and seminars	49580000	158200000
10	Other Expenses	155250000	-81930000
	Total other expenses	3779740000	12576420000
	Total expenses	27552650000	102545630000
3	Total profit before exceptional items and tax	5052080000	18223080000
4	Exceptional items	0	0
5	Total profit before tax	5052080000	18223080000
6	Tax expense
7	Current tax	1284730000	4721970000
8	Deferred tax	-190250000	-500500000
9	Total tax expenses	1094480000	4221470000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	3957600000	14001610000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	3957600000	14001610000
17	Other comprehensive income net of taxes	20440000	198290000
18	Total Comprehensive Income for the period	3978040000	14199900000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	3957590000	14001610000
	Total profit or loss, attributable to non-controlling interests	0	0
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	3977620000	14199490000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	779250000	779250000
	Face value of equity share capital	5	5
27	Details of debt securities
22	Reserves excluding revaluation reserve		62411400000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	25.64	91.22
	Diluted earnings (loss) per share from continuing operations	25.39	90.24
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	25.64	91.22
	Diluted earnings (loss) per share from continuing and discontinued operations	25.39	90.24
24	Debt equity ratio	0	0
25	Debt service coverage ratio	0	0
26	Interest service coverage ratio	0	0
27	Disclosure of notes on financial results		Due to character limitation in filling the notes in this tab, please refer to our submission under Ref. No. NSE & BSE / 2025-26 / 014 dated April 24, 2025, which covers the financial results under Regulation 33 of the SEBI (LODR) Regulations, 2015 including notes thereto.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	8149550000
	Capital work-in-progress	41840000
	Investment property	0
	Goodwill	12337950000
	Other intangible assets	4923330000
	Intangible assets under development	731770000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	6415040000
	Trade receivables, non-current	664400000
	Loans, non-current	0
	Other non-current financial assets	773810000
	Total non-current financial assets	7853250000
	Deferred tax assets (net)	2024240000
	Other non-current assets	1044560000
	Total non-current assets	37106490000
2	Current assets
	Inventories	0
	Current financial asset
	Current investments	3388170000
	Trade receivables, current	18477950000
	Cash and cash equivalents	6744060000
	Bank balance other than cash and cash equivalents	3510650000
	Loans, current	0
	Other current financial assets	9375160000
	Total current financial assets	41495990000
	Current tax assets (net)	0
	Other current assets	8763540000
	Total current assets	50259530000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	87366020000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	779250000
	Other equity	62411400000
	Total equity attributable to owners of parent	63190650000
	Non controlling interest	0
	Total equity	63190650000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	2582570000
	Total non-current financial liabilities	2582570000
	Provisions, non-current	66950000
	Deferred tax liabilities (net)	150490000
	Deferred government grants, Non-current	0
	Other non-current liabilities	47630000
	Total non-current liabilities	2847640000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	40770000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	8845400000
	Total Trade payable	8886170000
	Other current financial liabilities	3390700000
	Total current financial liabilities	12276870000
	Other current liabilities	4516470000
	Provisions, current	4028540000
	Current tax liabilities (Net)	505850000
	Deferred government grants, Current	0
	Total current liabilities	21327730000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	24175370000
	Total equity and liabilites	87366020000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Banking, Financial Services and Insurance (BFSI)	10468440000	37709680000
2	Healthcare & Life Sciences	8691780000	32551450000
3	Software, Hi-Tech and Emerging Industries	13260900000	49126040000
	Total Segment Revenue	32421120000	119387170000
	Less: Inter segment revenue	0	0
	Revenue from operations	32421120000	119387170000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Banking, Financial Services and Insurance (BFSI)	3695280000	13486460000
2	Healthcare & Life Sciences	3353500000	12768390000
3	Software, Hi-Tech and Emerging Industries	4377800000	14320530000
	Total Profit before tax	11426580000	40575380000
	i. Finance cost	183610000	183610000
	ii. Other Unallocable Expenditure net off Unallocable income	6190890000	6190890000
	Profit before tax	5052080000	18223080000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Banking, Financial Services and Insurance (BFSI)	7007190000	7007190000
2	Healthcare & Life Sciences	7163260000	7163260000
3	Software, Hi-Tech and Emerging Industries	14230620000	14230620000
	Total Segment Asset	28401070000	28401070000
	Un-allocable Assets	58964950000	58964950000
	Net Segment Asset	87366020000	87366020000
4	Segment Liabilities
	Segment Liabilities
1	Banking, Financial Services and Insurance (BFSI)	0	0
2	Healthcare & Life Sciences	0	0
3	Software, Hi-Tech and Emerging Industries	0	0
	Total Segment Liabilities	0	0
	Un-allocable Liabilities	24175370000	24175370000
	Net Segment Liabilities	24175370000	24175370000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of the defined benefit liabilities / asset	-14810000	193080000
	Total Amount of items that will not be reclassified to profit and loss	-14810000	193080000
2	Income tax relating to items that will not be reclassified to profit or loss	-2510000	49810000
3	Amount of items that will be reclassified to profit and loss
1	Effective portion of cash flow hedge (net of tax)	379030000	-34970000
2	Exchange differences in translating the financial statements of foreign operations	-256900000	81190000
	Total Amount of items that will be reclassified to profit and loss	122130000	46220000
4	Income tax relating to items that will be reclassified to profit or loss	89390000	-8800000
5	Total Other comprehensive income	20440000	198290000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			18223080000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			671290000
	Adjustments for decrease (increase) in inventories			0
	Adjustments for decrease (increase) in trade receivables, current			-2394690000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-3659190000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			197120000
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			1467510000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			3069100000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			422180000
	Adjustments for provisions, current			917690000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-2761880000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			559320000
	Adjustments for dividend income			0
	Adjustments for interest income			556420000
	Adjustments for share-based payments			3095270000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-569600000
	Other adjustments to reconcile profit (loss)			-535700000
	Other adjustments for non-cash items			-1461820000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-1539820000
	Net cash flows from (used in) operations			16683260000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			5114100000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			11569160000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			436140000
	Purchase of property, plant and equipment			4326500000
	Proceeds from sales of investment property			-1041040000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			570040000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			17020000
	Net cash flows from (used in) investing activities	-4344340000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			1845900000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			2061350000
	Payments of lease liabilities			1093660000
	Dividends paid			4600060000
	Interest paid			372820000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-6281990000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			942830000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			44620000
	Net increase (decrease) in cash and cash equivalents			987450000
	Cash and cash equivalents cash flow statement at beginning of period			5756610000
	Cash and cash equivalents cash flow statement at end of period			6744060000